FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period

Go back to FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period
(NASDAQ: FBRX) Delayed: 76.99 --0 (-0%)
Previous Close $76.99    52 Week High
Open $76.99    52 Week Low
Day High $76.99    P/E N/A 
Day Low $76.99    EPS
Volume 3,402,577